|
Market Closed -
OTC Markets
09:53:26 2021-11-09 EST
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
+9,900.00% | +9,900.00% |
| Market Cap | 1.04M 921K 861K 781K 1.47M 99.97M 1.49M 10.35M 4.02M 51M 3.89M 3.81M 164M | P/E 2015 |
-0.75x | P/E 2016 | -0.29x |
|---|---|---|---|---|---|
| Enterprise Value | -11.07M -9.83M -9.2M -8.34M -15.75M -1.07B -15.86M -110M -42.97M -545M -41.56M -40.67M -1.75B | EV / Sales 2015 |
-616,781,247x | EV / Sales 2016 | - |
| Free-Float |
100% | Yield 2015 * |
-
| Yield 2016 | - |
| 1 day | +9,900.00% | ||
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% | ||
| 1 month | +9,900.00% | ||
| 3 months | +9,900.00% | ||
| 6 months | +9,900.00% | ||
| Current year | +9,900.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0 | |
| 5 years | 0 | 0 | |
| 10 years | 0 | 0 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Talari
CEO | Chief Executive Officer | 64 | 2014-08-13 |
John Verghese
COO | Chief Operating Officer | 66 | - |
Karin Rohret
AUD | Comptroller/Controller/Auditor | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sam Talari
CHM | Chairman | 64 | 2014-08-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | +9,900.00% | +9,900.00% | +9,900.00% | 8.39K | ||
| +1.26% | -2.29% | +36.97% | +104.79% | 1,019B | ||
| +0.73% | -4.78% | +35.41% | +61.62% | 610B | ||
| +0.35% | +1.29% | +15.86% | +79.90% | 470B | ||
| +1.72% | -4.92% | +59.84% | +36.64% | 344B | ||
| +0.26% | +0.14% | +21.29% | +40.99% | 336B | ||
| +0.60% | -3.09% | +10.76% | +32.59% | 266B | ||
| +1.65% | -3.78% | -6.03% | +9.29% | 241B | ||
| -0.09% | -4.97% | +36.88% | +50.52% | 218B | ||
| -0.28% | -4.66% | +26.99% | +92.98% | 179B | ||
| Average | +990.34% | -3.34% | +1,013.80% | +1,040.93% | 368.28B | |
| Weighted average by Cap. | +0.05% | -3.43% | +29.52% | +67.02% |
| 2015 | 2016 | |
|---|---|---|
| Net sales | 0.05 0.05 0.04 0.04 0.08 5.2 0.08 0.54 0.21 2.65 0.2 0.2 8.53 | - |
| Net income | -1.41M -1.25M -1.17M -1.06M -2M -135M -2.01M -14.02M -5.45M -69.1M -5.27M -5.16M -222M | -644K -572K -535K -485K -916K -62.11M -923K -6.43M -2.5M -31.69M -2.42M -2.37M -102M |
| Net Debt | -34.28M -30.43M -28.48M -25.81M -48.75M -3.3B -49.1M -342M -133M -1.69B -129M -126M -5.42B | -12.11M -10.75M -10.06M -9.12M -17.22M -1.17B -17.35M -121M -46.99M -596M -45.46M -44.48M -1.91B |
Employees
8
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$0.000001 | -.--% | 100,000 |
- Stock Market
- Stocks
- FWDG Stock
Select your edition
All financial news and data tailored to specific country editions
















